Jasper Therapeutics, Inc.s largest shareholders are retail investors with 42 percent ownership, institutions ... - Yahoo Finance

JSPRW Stock  USD 0.20  0.01  5.26%   
Slightly above 55% of Jasper Therapeutics' sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Jasper Therapeutics suggests that some traders are interested. Jasper Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Jasper Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Jasper Therapeutics, Inc.s largest shareholders are retail investors with 42 percent ownership, institutions ... Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Jasper Therapeutics Fundamental Analysis

We analyze Jasper Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Jasper Therapeutics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Peers

Trending Equities

BBY  2.08   
0%
100.0%
TGT  1.71   
0%
82.0%
INTC  1.69   
0%
81.0%
AA  1.20   
0%
57.0%
AAPL  1.02   
0%
49.0%
C  1.01   
0%
48.0%
HD  0.45   
0%
21.0%
IBM  0.22   
0%
10.0%
UPS  0.03   
0%
1.0%
MET  0.02   
1.0%
0%
CVX  0.11   
5.0%
0%
CVS  0.18   
8.0%
0%
S  0.46   
22.0%
0%
T  0.47   
22.0%
0%
AAL  0.82   
39.0%
0%
WFC  1.35   
64.0%
0%

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.